deltatrials
Unknown NA NCT00017654

Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia

Sponsor: Northwestern Memorial Hospital

Conditions Aplastic Anemia Graft Versus Host Disease
Interventions Allogeneic Bone Marrow Transplantation anti-thymocyte globulin cyclophosphamide cyclosporine methylprednisolone
Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Apr 30, 2001

Listed as NCT00017654, this NA trial focuses on Aplastic Anemia and Graft Versus Host Disease and remains ongoing. Sponsored by Northwestern Memorial Hospital, it has been updated 5 times since 2001, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status NA

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status NA

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status NA

    First recorded

Apr 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Northwestern Memorial Hospital
Data source: Office of Rare Diseases (ORD)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Chicago, United States